MK-571
产品编号: DC9279
Featured
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
MK-571 sodium salt是一种选择性，口服活性的白三烯D4受体拮抗剂，在豚鼠和人肺膜的Ki分别为0.22 和 2.1 nM。
| Cas No.: |
115103-85-0 |
| 名称: |
(E)-3-[[[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]-propanoic acid, sodium salt |
| 别名: |
L-660,711，MK571，MK 571，L660711,L-660711 |
| SMILES: |
CN(C)C(=O)CCSC(C1=CC=CC(=C1)/C=C/C2=NC3=C(C=CC(=C3)Cl)C=C2)SCCC(=O)[O-].[Na+] |
| 分子式: |
C26H26ClN2O3S2Na |
| 分子量: |
537.07 |
| 纯度: |
|
| 保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: |
|
| In Vivo: |
|
| In Vitro: |
|
| References: |
MK-571 has been reported to be a selective competitive inhibitor of [3H]leukrotriene D4 (LTD4) binding to CysLT1 receptors. LTD4 has been shown to induce contractions in guinea pig trachea and human lung membranes. Cysteinyl leukotrienes have also been identified as important pro-inflammatory mediators, therefore making MK-571 an anti-inflammatory agent. This compound demonstrates inhibitory characteristics of Mdr-1 (multidrug resistance protein-1) mediated transport. Additionally, studies suggest that this agent can augment the effects of cytotoxic agents on cells in vitro. MK-571 is an inhibitor of MRP1 and CysLT1 Receptor. |
| Kinase Assay: |
|
| Cell Assay: |
|
| Animal Administration: |
|
| References: |
|
MSDS
COA
| LOT NO. |
DOWNLOAD |
|
|
| 2018-0101 |
|
询盘
